Startups

Psylink logo

Psylink

Psylink is a Lithuanian biotechnology company developing small-molecule medicines for mental health conditions, including treatment-resistant depression and PTSD. It engineers yeast to biosynthesise plant- and fungi-derived compounds, including psilocybin and related molecules, and screens new compounds for further drug development. Its platform aims to provide a scalable supply of research materials while discovering potential next-generation therapies through neuroscience and natural-product research.

Team

Aiste LengvenyteClinical Advisor
Evaldas CiplysCo-founder & Chief Scientific Officer
Laura KorsakovaCo-founder & Chief Executive Officer
Osvaldas RuksenasScientific Advisor
Robertas StrumilaClinical Advisor

Investments